Magnisense

Magnisense is a health care startup that has been making waves in the industry since its founding in 2003. The company's slogan "Creating rapid diagnostic solutions for cardiovascular illnesses through proprietary MIAtek® technology and advanced diagnostic instruments" embodies its core mission. In its most recent funding round in October 2018, Magnisense secured a notable €5.00M Venture Round investment. This funding came from a consortium of investors including Noshaq, Provestis SAS, Concorde Capital, Victor Douce, and Minv. The company's innovative approach to emergency diagnostic tests for cardiovascular diseases, leveraging its proprietary MIAtek® technology, has captured the attention and investment of these prominent players in the industry.